Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis-Reference-Cited by-同舟云学术

Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis

Published:2011-06 Issue:85 Volume:3 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Fornoni Alessia¹²,Sageshima Junichiro³,Wei Changli¹,Merscher-Gomez Sandra¹,Aguillon-Prada Robier¹,Jauregui Alexandra N.¹²,Li Jing¹,Mattiazzi Adela¹,Ciancio Gaetano³,Chen Linda³,Zilleruelo Gaston⁴,Abitbol Carolyn⁴,Chandar Jayanthi⁴,Seeherunvong Wacheree⁴,Ricordi Camillo²³,Ikehata Masami⁵,Rastaldi Maria Pia⁵,Reiser Jochen¹,Burke George W.²³

Affiliation:

1. Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

2. Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

3. Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

4. Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

5. Renal Research Laboratory, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico and Fondazione D’Amico per la Ricerca sulle Malattie Renali, 20145 Milan, Italy.

Abstract

Rituximab treatment in high-risk patients with focal segmental glomerulosclerosis directly affects podocyte function and is linked to reduced incidence of recurrent proteinuria after kidney transplantation.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference40 articles.

1. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States

2. Hereditary Proteinuria Syndromes and Mechanisms of Proteinuria

3. Outcomes after renal transplantation for FSGS in children

4. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts

5. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience

Cited by 454 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingolipids and Chronic Kidney Disease;Journal of Clinical Medicine;2024-08-26

2. The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte;American Journal of Nephrology;2024-07-29

3. New sights into new‐onset and relapsed minimal change disease post COVID‐19 vaccination: A systemic review of the clinical characteristics and underlying pathogenesis;Rheumatology & Autoimmunity;2024-06-28

4. Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective study;Journal of the Formosan Medical Association;2024-06

5. Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft;Nephrology Dialysis Transplantation;2024-05-24